Download Citation
Article Source:
Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway
Zhao Sp,
Li R,
Dai W,
Yu Bl,
Chen Lz,
et al.
(2017)
Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
PLOS ONE 12(9): e0184949.
https://doi.org/10.1371/journal.pone.0184949